| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 138384-42-6 | Benz[cd]indol-2(1H)-one,6-[ethyl[[4-(1-piperazinylsulfonyl)phenyl]methyl]amino]-; Piperazine,1-[[4-[[(1,2-dihydro-2-oxobenz[cd]indol-6-yl)ethylamino]methyl]phenyl]sulfonyl]-(9CI); Benz[cd]indole, piperazine deriv. |  | C24H26N4O3S | 詳情 | 供應(yīng)商 | |
| 84468-24-6 | 1-(5-異喹啉基磺酰)哌嗪二鹽酸鹽 | Isoquinoline,5-(1-piperazinylsulfonyl)-; Piperazine,1-(5-isoquinolinylsulfonyl)- (9CI); 1-(5-Isoquinolinylsulfonyl)piperazine; HA100; HA 100 (pharmaceutical) |  | C13H15N3O2S | 詳情 | 供應(yīng)商 |
| 110408-10-1 | Isoquinoline,5-chloro-8-(1-piperazinylsulfonyl)-; Piperazine,1-[(5-chloro-8-isoquinolinyl)sulfonyl]- (9CI); CKI 8; HA 140 |  | C13H14ClN3O2S | 詳情 | 供應(yīng)商 | |
| 110408-11-2 | Isoquinoline,8-(1-piperazinylsulfonyl)-; Piperazine,1-(8-isoquinolinylsulfonyl)- (9CI); HA 142; HA 142 (pharmaceutical) |  | C13H15N3O2S | 詳情 | 供應(yīng)商 | |
| 110408-12-3 | Isoquinoline,8-chloro-5-(1-piperazinylsulfonyl)-; Piperazine,1-[(8-chloro-5-isoquinolinyl)sulfonyl]- (9CI); HA 156 |  | C13H14ClN3O2S | 詳情 | 供應(yīng)商 | |
| 247582-73-6 | 3-Pyridinecarboxylicacid, 2-ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]-; 2-Ethoxy-5-(4-ethyl-1-piperazinylsulfonyl)nicotinicacid; 3-Carboxy-2-ethoxy-5-(4-ethylpiperazin-1-ylsulfonyl)pyridine |  | C14H21N3O5S | 詳情 | 供應(yīng)商 | |
| 139755-82-1 | N-去甲基西地那非 | DESMETHYL SILDENAFIL; DESMETHYL SILDENAFIL; 5-[2-Ethoxy-5-(1-piperazinylsulfonyl)phenyl]-1,6-dihydro-1-methyl-3-propyl- 7H-pyrazolo[4,3-d]pyrimidin-7-one; UK 103320 |  | C21H28N6O4S | 詳情 | 供應(yīng)商 |